Fig. 2
From: Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival
Kaplan-Meier survival analysis of the breast cancer patients according to mRNA and protein expression levels. Patients were divided into high and low expression groups relative to the median expression values. Expression of a, TMPRSS1 mRNA (median follow-up time 9.84Â years); b, TMPRSS3 mRNA (median follow-up time 9.54Â years); c, hepsin protein (median follow-up time 11.05Â years); and d, TMPRSS3 protein (median follow-up time 10.94Â years)